The molecular mechanisms of allosteric mutations impairing MepR repressor function in multidrug-resistant strains of

Ivan Birukou1, Nam K Tonthat, Susan M Seo

  • 1Department of Biochemistry, Duke University School of Medicine, Durham, North Carolina, USA.

Mbio
|August 29, 2013
PubMed
Abstract

Insights

Mutations in the MepR repressor

Area of Science:

  • Microbiology
  • Structural Biology
  • Biochemistry

Background:

  • Staphylococcus aureus is a significant threat, often developing multidrug resistance.
  • Overexpression of the MepA efflux pump drives this resistance.
  • MepR, a repressor of mepA, is frequently mutated in resistant strains.

Purpose of the Study:

  • To elucidate the structural basis of MepR mutations causing multidrug resistance in S. aureus.
  • To understand how linker region mutations disrupt MepR's DNA binding and repressor function.
  • To reveal novel allosteric mechanisms in MarR family repressors.

Main Methods:

  • X-ray crystallography to determine structures of wild-type and mutant MepR.
  • Biochemical assays to quantify DNA binding affinity.
  • Structure-function analysis of MepR variants (A103V, F27L, Q18P).

Main Results:

  • Determined structures of three clinically relevant MepR mutants (A103V, F27L, Q18P) and wild-type MepR.
  • Mutations, located in the linker region, significantly reduce MepR's DNA binding affinity (27- to 2,000-fold).
  • Specific mutations cause conformational changes, displacing DNA-binding domains or altering helix structures.

Conclusions:

  • Linker region mutations in MepR dysregulate its function through allosteric mechanisms.
  • These structural changes impair MepR's ability to bind DNA, leading to mepA overexpression and multidrug resistance.
  • Understanding these mechanisms is crucial for combating multidrug-resistant Staphylococcus aureus.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mismatch Repair01:36

Mismatch Repair

Overview
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...